Status: Not yet recruiting
WATER IV PCa (AS Sub-study)
The WATER IV study is a multicenter, prospective, randomized clinical trial that aims to evaluate the safety and efficacy of Aquablation therapy in men with localized prostate cancer.
Participants needed: 333
Trial details
Age: 45+Biological sex: MaleType: InterventionalSponsor: PROCEPT BioRoboticsUpdated: Jun 23, 2026Locations: 17
Eligibility criteria
Biological male with age ≥ 45 years at the time of consent [+6]
Any prior or current local or systemic treatment for prostate cancer, including... [+3]